HOME >> BIOLOGY >> NEWS
Surgical Experience Improves Thyroidectomy Outcome

, 30 to 100 operations (group C), and more than 100 operations (group D).

After taking into consideration patient age, race, and other existing medical problems to produce a more accurate comparison, the researchers found significant differences in the four categories of surgeons. Patients whose surgeons did the most thyroid operations (group D) had the shortest length of hospital stay (1.4 days versus 1.7 days for groups B and C and 1.9 days for group A. These patients also had the lowest complication rate (5.1 percent for group D versus 6.1 for groups B and C and 8.6 for group A). In fact, the surgeon who performed the most thyroid operations among all the surgeons had the lowest complication rate (2.4 percent), shortest length of stay (1.1 days) and lowest average hospital charges ($2,990).

The superior clinical outcomes produced by greater surgical experience also translated into cost savings for thyroid cancer operations. For surgeons performing the greatest number of cancer surgeries, the average hospital charge was $3,553, versus $3,978 for group C surgeons; $4,046 for group B doctors, and $4,416 for those doctors in group A.

"In an era of ever increasing cost containment, we need to demonstrate outcome data to determine how to allocate limited resources," Udelsman says. Toby Gordon, Sc.D., a coauthor of the study and associate professor of surgery at Hopkins, says, "These kinds of outcomes studies underscore the importance of surgical experience in obtaining the best clinical results for patients and the best economic results for payers."


'"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
7-Oct-1998


Page: 1 2

Related biology news :

1. Study Affirms Value Of Non-Surgical Treatment For Arrhythmia
2. Non-Surgical Treatment Ends Pelvic Pain In Women
3. Molecular Modeling Expands Chemistry Students Experiences
4. HIV Patients Often Experience Viral "Breakthrough," But May Still Remain Healthy, San Francisco Study Finds
5. Different Molecular Events Underly Experience-Dependent Loss And Gain Of The Function Of The Developing Brain
6. NASA Exhibit In San Francisco To Show How Space Research Improves Health Care On Earth
7. Sick Kids Improves Access To Global Genome Database
8. Fortified Drink Improves Third World Nutrition
9. New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions
10. UPCI Researchers Find Drug Improves Cancer-Fighting Ability Of Vitamin D
11. Peptic Ulcer Treatment Improves Health, Saves Money

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that it has entered into a ... multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to ...
(Date:6/23/2020)... KEYNES, England (PRWEB) , ... June 23, 2020 ... ... in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer ... response project to support testing operations in the fight against the COVID-19 pandemic ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/1/2020)... CHARLOTTE, N.C. (PRWEB) , ... June 29, 2020 ... ... has reported year to date growth of 40% in 2020, despite many obstacles ... medical technology, MedShift aims to increase revenue for its partnered medical practices and ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... to advance photodynamic therapy for treating cancer, today announced the company has entered ... (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., ... presented June 22-24 during the American Association for Cancer Research Virtual meeting. One ... the potent, consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
Breaking Biology Technology:
Cached News: